Thu, Oct 17 4:57am


JAZZ $119.77 1.72 (1.46%)
Jazz Pharmaceuticals PLC
NASDAQ: JAZZ $7 Billion Mid-Cap. Biotech & Pharma industry. 5 Year Return 21%. 1 Year Return 23%. 2019 YTD Return 4%. Negative 5 year, 1 year & YTD returns. You may want to avoid this one until things turn around. Check out some Uptrending symbols instead. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

JAZZ Profile

Market Cap 7 Billion
JAZZ Description

Jazz Pharmaceuticals is an Ireland-domiciled specialty pharmaceutical firm focused primarily on treatments for orphan drug indications. Jazz's product portfolio includes lead drug Xyrem for narcolepsy, Erwinaze for acute lymphoblastic leukemia, Defitelio for severe veno-occlusive disease, and Vyxeos for acute myeloid leukemia.

Visit Website

JAZZ Earnings

EPS 4.62 P/E Ratio 17.26
Previous Tue, Aug 6, 2019
Latest Tue, Nov 5, 2019 (In 19 days)

JAZZ Dividend

Yield --
Ex-Date --
Pay Date --
History --

JAZZ Charts

52 Week Low $113.52 set on Mon, Dec 24, 2018
1 Year
Dec 24, 2018
Nov 2, 2018

Symbol Price Day Ξ” YTD Ξ”
JAZZ $119.77 1.46% -4.28%


Symbol Surfing

How can we make Symbol Surfing better?

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy